Company Search:
Advanced Search
Sponsored Links
Vernalis Plc Company Snapshot
Vernalis Plc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vernalis Plc with three other companies in this sector in the United Kingdom: Redx Pharma PLC (2017 sales of £30.47 million [US$42.56 million] ), Bioventix Plc (£7.25 million [US$10.12 million] ), and Genedrive PLC (£5.79 million [US$8.08 million] of which 45% was Diagnostics Segment).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vernalis Plc
  Stock Performance Chart for Vernalis Plc
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 3.20p
(Figures in Pounds Sterling)
1 Week -24.3%   13 Weeks -49.4%  
4 Weeks -63.4%   52 Weeks -86.8%  
Vernalis Plc Key Data:
  Ticker: VER Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 20,790,000
(Year Ending Jan 2018).
Employees: 115
  Currency: Pounds Sterling Market Cap: 16,858,228
  Fiscal Yr Ends: June Shares Outstanding: 526,819,624
  Share Type: Ordinary Closely Held Shares: 6,550,937
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.